THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
Systems Biology Ireland investigates new therapeutic approaches to disease on a systemic level using a combination of traditional wet-lab experimental analyses with computational modelling and simulation. The Eissner Group’s focus is on endothelial and mesenchymal stem cells in transplant medicine and oncology, i.e. the monitoring and preventing endothelial-specific adverse immunological reactions in transplant settings.
In WP5 we investigate the influence of COVID-19-triggered cytokines, as known to be present in patients’ sera, on viability, immunological as well as phenotypic changes, and transendothelial migration across human microvascular pulmonary endothelial cells. We also assess the protective role of FX06 to interfere with these pro-inflammatory actions and the underlying mechanism of action of the drug with wet and dry lab approaches.